Dianthus Therapeutics Statistics
Total Valuation
DNTH has a market cap or net worth of $3.56 billion. The enterprise value is $3.04 billion.
Important Dates
The last earnings date was Monday, March 9, 2026, before market open.
| Earnings Date | Mar 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DNTH has 44.47 million shares outstanding. The number of shares has increased by 15.92% in one year.
| Current Share Class | 52.94M |
| Shares Outstanding | 44.47M |
| Shares Change (YoY) | +15.92% |
| Shares Change (QoQ) | +18.99% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 94.39% |
| Float | 49.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,747.39 |
| Forward PS | 3,163.22 |
| PB Ratio | 7.01 |
| P/TBV Ratio | 7.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,495.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.32, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.32 |
| Quick Ratio | 13.16 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.38% and return on invested capital (ROIC) is -26.21%.
| Return on Equity (ROE) | -38.38% |
| Return on Assets (ROA) | -24.58% |
| Return on Invested Capital (ROIC) | -26.21% |
| Return on Capital Employed (ROCE) | -35.57% |
| Weighted Average Cost of Capital (WACC) | 11.05% |
| Revenue Per Employee | $22,130 |
| Profits Per Employee | -$1.76M |
| Employee Count | 92 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +285.73% in the last 52 weeks. The beta is 1.24, so DNTH's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +285.73% |
| 50-Day Moving Average | 55.55 |
| 200-Day Moving Average | 36.75 |
| Relative Strength Index (RSI) | 71.93 |
| Average Volume (20 Days) | 1,349,276 |
Short Selling Information
The latest short interest is 7.89 million, so 17.75% of the outstanding shares have been sold short.
| Short Interest | 7.89M |
| Short Previous Month | 8.10M |
| Short % of Shares Out | 17.75% |
| Short % of Float | 15.82% |
| Short Ratio (days to cover) | 10.78 |
Income Statement
In the last 12 months, DNTH had revenue of $2.04 million and -$162.34 million in losses. Loss per share was -$4.20.
| Revenue | 2.04M |
| Gross Profit | 2.04M |
| Operating Income | -177.93M |
| Pretax Income | -162.34M |
| Net Income | -162.34M |
| EBITDA | -177.82M |
| EBIT | -177.93M |
| Loss Per Share | -$4.20 |
Full Income StatementBalance Sheet
The company has $404.30 million in cash and $1.39 million in debt, with a net cash position of $513.04 million or $11.54 per share.
| Cash & Cash Equivalents | 404.30M |
| Total Debt | 1.39M |
| Net Cash | 513.04M |
| Net Cash Per Share | $11.54 |
| Equity (Book Value) | 493.40M |
| Book Value Per Share | 11.42 |
| Working Capital | 378.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$129.06 million and capital expenditures -$213,000, giving a free cash flow of -$129.27 million.
| Operating Cash Flow | -129.06M |
| Capital Expenditures | -213,000 |
| Free Cash Flow | -129.27M |
| FCF Per Share | -$2.91 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -8,739.34% |
| Pretax Margin | -7,973.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DNTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.92% |
| Shareholder Yield | -15.92% |
| Earnings Yield | -4.56% |
| FCF Yield | -3.63% |
Analyst Forecast
The average price target for DNTH is $123.09, which is 53.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $123.09 |
| Price Target Difference | 53.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 200.22% |
| EPS Growth Forecast (5Y) | -12.53% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DNTH has an Altman Z-Score of 14.07 and a Piotroski F-Score of 1.
| Altman Z-Score | 14.07 |
| Piotroski F-Score | 1 |
